Danaher (NYSE:DHR – Get Free Report) had its target price cut by equities researchers at Robert W. Baird from $277.00 to $268.00 in a research note issued to investors on Tuesday. The brokerage currently has an “overweight” rating on the conglomerate’s stock. Robert W. Baird’s price target suggests a potential upside of 20.11% from the stock’s previous close.
A number of other brokerages have also weighed in on DHR. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research note on Friday, December 13th. Stifel Nicolaus upped their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. KeyCorp upped their target price on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Royal Bank of Canada reduced their target price on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Six investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $284.14.
Check Out Our Latest Stock Analysis on DHR
Danaher Price Performance
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same period in the previous year, the company posted $2.09 earnings per share. On average, research analysts expect that Danaher will post 7.5 EPS for the current year.
Hedge Funds Weigh In On Danaher
A number of hedge funds have recently bought and sold shares of DHR. Heck Capital Advisors LLC bought a new position in Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. bought a new position in Danaher during the fourth quarter worth $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the fourth quarter valued at $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher in the fourth quarter valued at $31,000. Finally, Pineridge Advisors LLC increased its stake in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Steel Stocks Soaring After Tariff Announcements
- Why is the Ex-Dividend Date Significant to Investors?
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.